Latest Health News

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

Beacon Minerals has announced a $12 million on-market share buy-back program aiming to enhance shareholder value and capital efficiency, with purchases starting August 1, 2025.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

Australian Unity Limited has agreed to acquire Plena Healthcare for $70 million, significantly scaling its Home Health services and workforce. The move aims to create one of Australia's leading integrated healthcare providers, pending regulatory approval.

Broken Hill Mines Limited will have its trading suspension lifted on 21 July 2025, marking its return to the ASX following successful compliance with listing rules.

Chemx Materials Limited has successfully completed its Deed of Company Arrangement, exiting external administration and returning control to its directors. Creditors will soon be contacted regarding dividend payments from the creditors trust.

Ironbark Capital Limited has announced an on-market buy-back of up to 10.46 million ordinary shares, commencing July 21, 2025, and running through to July 2026. This move signals a strategic capital management initiative without requiring shareholder approval.

Burgundy Diamond Mines pauses open pit mining at Point Lake due to weak diamond prices, focusing instead on higher-margin underground operations at Misery. The company also prepares to unveil a new mine plan and Fox project study.

4DMedical has renewed its three-year contract with the University of Michigan Medical Center, reinforcing its foothold in US respiratory imaging. Alongside, a pivotal clinical study validates its technology’s ability to detect early lung disease, while a substantial Australian grant boosts its AI research.

Hillgrove Resources reported operational gains and exploration success in Q2 2025, despite lower copper output due to grade variability. The Nugent acceleration project is progressing ahead of schedule, setting the stage for increased throughput and cost efficiencies in 2026.

McPherson’s Limited anticipates FY25 revenue around $139 million with a strong second-half EBITDA rebound, while its strategic shift to third-party wholesalers sets the stage for significant EBIT gains in FY26.